Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2023-06-02 4:46 pm Purchase | 13G | TRACON Pharmaceuticals, Inc. TCON | Lincoln Park Capital Fund LLC | 2,369,821 8.98% | 2,369,821![]() (New Position) | View |
2023-04-24 4:33 pm Purchase | 13G | Windtree Therapeutics, Inc. WINT | Lincoln Park Capital Fund LLC | 459,042 9.99% | 459,042![]() (New Position) | View |
2023-02-06 6:34 pm Purchase | 13G | Ensysce Biosciences, Inc. ENSC | Lincoln Park Capital Fund LLC | 1,501,055 9.99% | 1,501,055![]() (New Position) | View |
2022-10-25 06:01 am Sale | 13G | Cellectar Biosciences, Inc. CLRB | Lincoln Park Capital Fund LLC | 937,588 9.99% | -1,376,095![]() (-59.48%) | View |
2022-07-28 5:09 pm Purchase | 13G | Kiora Pharmaceuticals, Inc. KPRX | Lincoln Park Capital Fund LLC | 3,280,476 9.99% | 3,280,476![]() (New Position) | View |
2022-05-18 12:34 pm Purchase | 13G | Vallon Pharmaceuticals, Inc. VLON | Lincoln Park Capital Fund LLC | 1,050,232 9.99% | 1,050,232![]() (New Position) | View |
2022-04-27 10:52 am Purchase | 13G | Salarius Pharmaceuticals, Inc. SLRX | Lincoln Park Capital Fund LLC | 2,969,718 5.98% | 2,969,718![]() (New Position) | View |
2022-01-19 11:05 am Purchase | 13G | X4 Pharmaceuticals, Inc. XFOR | Lincoln Park Capital Fund LLC | 1,810,087 6.44% | 1,810,087![]() (New Position) | View |
2021-11-19 12:57 pm Purchase | 13G | Nabriva Therapeutics plc NBRV | Lincoln Park Capital Fund LLC | 4,512,589 7.96% | 4,512,589![]() (New Position) | View |
2021-04-28 5:22 pm Purchase | 13G | Benitec Biopharma Inc. BNTC | Lincoln Park Capital Fund LLC | 423,529 5.392% | 423,529![]() (New Position) | View |
2021-01-15 6:21 pm Purchase | 13G | Viveve Medical, Inc. VIVE | Lincoln Park Capital Fund LLC | 701,000 9.99% | 701,000![]() (New Position) | View |
2021-01-08 4:38 pm Purchase | 13G | Onconova Therapeutics, Inc. ONTX | Lincoln Park Capital Fund LLC | 13,639,411 6.52% | 13,639,411![]() (New Position) | View |
2020-11-13 06:01 am Purchase | 13G | Moleculin Biotech, Inc. MBRX | Lincoln Park Capital Fund LLC | 4,787,254 7.52% | 4,787,254![]() (New Position) | View |
2020-08-03 4:03 pm Purchase | 13G | Advaxis, Inc. ADXS | Lincoln Park Capital Fund LLC | 4,594,793 6.94% | 4,594,793![]() (New Position) | View |
2020-07-13 2:38 pm Purchase | 13G | Cellectar Biosciences, Inc. CLRB | Lincoln Park Capital Fund LLC | 2,313,683 8.92% | 2,313,683![]() (New Position) | View |
2020-03-02 09:27 am Purchase | 13G | Imunon, Inc. CLSN | Lincoln Park Capital Fund LLC | 1,581,429 5.49% | 1,581,429![]() (New Position) | View |
2020-02-27 1:48 pm Purchase | 13G | Brickell Biotech, Inc. BBI | Lincoln Park Capital Fund LLC | 965,723 9.99% | 965,723![]() (New Position) | View |
2020-01-29 06:02 am Purchase | 13G | VistaGen Therapeutics, Inc. VTGN | Lincoln Park Capital Fund LLC | 4,614,602 9.62% | 4,614,602![]() (New Position) | View |
2019-11-01 7:44 pm Purchase | 13G | Trovagene Inc. TROV | Lincoln Park Capital Fund LLC | 798,121 9.99% | 798,121![]() (New Position) | View |
2019-06-07 3:41 pm Purchase | 13G | Westwater Resources, Inc. WWR | Lincoln Park Capital Fund LLC | 104,294 6.5% | 104,294![]() (New Position) | View |